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Abstract
Substantial effort has been focused on the development of highly efficient gene transfer strategies. Although viral and
non-viral methods have been elaborated, mechanisms of gene delivery are still poorly understood. We exploited our recent
observation that replication-deficient type 5 adenovirus dramatically enhances lipofectAMINE-mediated gene transfer
 .lipoadenofection in differentiated cells to elucidate the mechanism of adenovirus action in this process. Heat-induced
denaturation of viral capsid abolishes adenovirus action whereas inactivation of viral genome by short treatment with UV
has no effect. Electron microscopic observations reveal the formation of a complex containing adenovirus and lipofec-
tAMINE which probably carries DNA into cells via endocytosis. Anti-adenovirus antiserum or monoclonal anti-a bv 3
integrin antibody inhibits lipoadenofection, at least partially. Neutralization of endosomal compartments with chloroquine,
ammonium chloride or monensin does not prevent adenovirus improvement of gene transfer. Hence, adenovirus–lipo-
fectAMINE–DNA complexes in which viral particles are each encompassed by three lipid layers, penetrate cells via an
endocytic pathway involving probably the adenovirus receptor and a b integrin. The resulting efficient transfer andv 3
expression of plasmid DNA proceeds from a mechanism in which adenoviral endosomolytic activity appears to be required
while viral genome is not essential. q 1997 Elsevier Science B.V.
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1. Introduction
Gene transfer by non-viral methods remains a
poorly efficient process, particularly in terminally
differentiated cells. Two types of vectors have been
widely employed. Soluble DNA-protein complexes
utilize the targeting capacity of a ligand that is recog-
) Corresponding author. Fax: q33-1-45075890.
nized by a specific receptor at the cell surface and is
conjugated to poly-L-lysine to which plasmid DNA is
w xassociated 1,2 . Cationic liposomes or polyethylen-
 .imine PEI allow formation of a condensed structure
in which positive charges of the vector interact with
w xnegatively-charged phosphate DNA 3–5 . At least in
the case of lipid–DNA complexes, receptor-indepen-
dent endocytosis has been demonstrated as being the
w xmajor pathway of entry into cells 6,7 . The limiting
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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step for efficient gene transfer using non-viral meth-
ods is the intra-endosomal DNA breakdown consecu-
w xtive to fusion of endosomes to lysosomes 7 . With
the aim of overcoming this degradation process, the
idea has emerged that the endosomolytic property of
adenovirus could be exploited.
In the past few years, we and others have devel-
oped approaches using the association of replication-
deficient adenovirus and either naked plasmid DNA
w x w x8 , poly-L-lysine–DNA conjugates 2,9–11 , cationic
w x w x w xliposomes 12–16 or PEI 17 in a covalent 10,11
w xor non-covalent 2,9,12–17 manner. Such associa-
tions actually dramatically enhance gene transfer effi-
ciency in various cell types. Moreover, combination
of adenovirus with either lipofectAMINE or PEI has
been proved adequate for transfection of plasmid
DNA in cultured adipocytes, muscle or hepatocytic
cells, three highly differentiated cells almost impervi-
w xous to efficient transfection by other means 12 .
Mechanisms by which adenovirus improves non-
viral-mediated gene transfer are poorly documented.
It is known however that covalent coupling of aden-
ovirus to poly-L-lysine–DNA conjugates induces for-
mation of a complex which enters cells at least in
part through adenovirus receptor-mediated endocyto-
w xsis 18 . In this report, we have addressed the ques-
tion of how non-covalent association of adenovirus to
cationic liposome–DNA complexes permits a better
lipofection efficiency in differentiated cells. We
demonstrate that a complex between adenovirus, lipo-
fectAMINE and plasmid DNA penetrates adipose
cells via an endocytic process which probably in-
volves the adenovirus receptor and a cellular integrin.
We show also that neutralization of endosomal pH is
not deleterious to gene transfer enhancement.
2. Materials and methods
2.1. Plasmid and cell culture
The plasmid pSV2-CAT SV40 promoter fused to
 . .the chloramphenicol acetyltransferase CAT gene
w xwas described elsewhere 19 . Plasmid was prepared
by two successive equilibrium centrifugations in ce-
sium chloriderethidium bromide gradient. 3T3-
w xF442A adipoblasts 20 were cultured in 60 mm
 .dishes Falcon at 378C in a humidified atmosphere
of 10% CO r90% air. Cells were grown in Dul-2
 . becco’s modified Eagle medium DMEM Gibco
. y1 y1BRL containing 200 IU ml penicillin, 50 mg l
streptomycin, 8 mg ly1 biotin, 4 mg ly1 pantothenate
and 3.7 g ly1 bicarbonate and supplemented with
10% fetal calf serum. Adipose differentiation was
achieved in the same medium supplemented with
0.02 mM insulin for 7 days. Medium was changed
every other day.
2.2. Adeno˝irus propagation and treatment
The replication-deficient recombinant type 5
adeno-virus Ad-RSV-nlsLacZ Rous sarcoma virus
. w xpromoter driving the nlsLacZ gene 21 was propa-
gated in human embryonic kidney cell line 293
 . w xATCC collection as previously described 22 . Ade-
novirus was purified by banding on two successive
cesium chloride gradients, dialyzed against phosphate
buffered saline containing 10% glycerol, and stored
at y808C. Viral titers were determined by plaque
assay using 293 cells. For genome inactivation, adeno-
virus was exposed to 260 nm UV light source on ice
at 4 cm from the lamp, for 1, 2 or 5 min. For
alteration of capsid protein, virus was heated at 458C
w xfor 10 min 23 .
2.3. Gene transfer procedure
 .Plasmid DNA 5 mg and 18.6 ml lipofectAMINE
 .Gibco BRL were separately diluted into 50 ml of
DMEM in polystyrene tubes, then gently mixed to-
 .gether 10"charge ratio . After 10 min, adenovirus
  . y1.200 plaque forming units pfu cell was added or
not to the lipid–DNA complex prior dilution in 2 ml
of serum-free medium which was subsequently added
to a 60 mm dish containing ca. 3=106 differentiated
cells. 7 h later, medium was changed to 4 ml of
DMEM containing 10% fetal calf serum. Cells were
harvested 16 h later.
2.4. Adeno˝irus infection and CAT and b-galacto-
sidase assays
Preparation of cell homogenates for CAT assays
w xwas performed as detailed elsewhere 12 . The method
w xof Seed and Sheen 24 was used for determination of
CAT activity. For measurement of adenovirus infec-
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tivity, cells were incubated in 2 ml of culture medium
containing 200 pfu celly1 of native or UV light-
treated adenovirus for 7 h. b-galactosidase was de-
tected 16 h later either by determination of enzymatic
w xactivity as described previously 25 or by staining as
follows. Cells were rinsed with phosphate buffered
saline, fixed and stained with 5-bromo-4-chloro-3-in-
w xdolyl-b-D-galactoside as described 26 . Blue nuclei
corresponding to b-galactosidase expressing cells
were counted under the microscope 8 h after staining.
2.5. Electron microscopy
Negatively stained material for gene transfer were
observed by electron microscopy. Lipid–DNA com-
plexes were achieved with 5 mg of pSV2-CAT and
lipofectAMINE in a 1r10 positive charge ratio, then
 y1.adenovirus was added 200 pfu cell or not. Trans-
fection materials were adsorbed on colodion coated
nickel grids, air dried, stained with 0.5% aqueous
solution of phosphotungstate and visualised with a
transmission electron microscope. Lipofection or
lipoadenofection were carried out on 3T3-F442A
adipocytes cultured in 35 mm dishes for 30 min, then
fixed with 1% glutaraldehyde for 2 h at 48C. Standard
electron microscopy procedure was achieved as pre-
w xviously described 27 . Briefly, cells were post-fixed
in 1% osmium tetroxide and dehydrated in graded
series of ethanol. Embedded Eponate blocks were
sectioned. Sections were stained with uranyl acetate
and lead then examined with a transmission electron
microscope.
2.6. Neutralization with antibodies
Adenovirus was treated with a polyclonal anti-
serum from rabbit which had been obtained after
three intramuscular immunizations with adenovirus
w xserotype 5 28 . This antiserum contains neutralizing
antibodies directed against proteins of the adenoviral
capsid. This serum was used at a dilution of 1r100
for 30 min at 378C prior addition to the lipid–DNA
complex. Pre-immune serum was used under the
same conditions as a control. To neutralize a bv 3
integrin, cells were treated with hamster anti-mouse
 y1.  .monoclonal anti-b IgG 25 mg ml Pharmingen3
in serum-free DMEM for 30 min before proceeding
to lipoadenofection.
2.7. Cell treatment with weak bases and ionophores
Differentiated cells were incubated with either 100
mM chloroquine, 10 mM ammonium chloride or 5
mM monensin for 30 min. Then lipoadenofection was
carried out in the presence of these agents. For
controlling acidification of endosomes, 3T3-F442A
adipocytes were pretreated with either 100 mM
chloroquine, 10 mM ammonium chloride or 5 mM
monensin for 30 min then 1 mM acridine orange was
added for 30 min. Acridine orange accumulates in
acidic compartments resulting in fluorescent red
staining. Cells were immediately observed under mi-
croscope with a 546 nm filter.
3. Results and discussion
3.1. Adeno˝irus capsid but not ˝iral genome is essen-
tial for lipoadenofection
Adenovirus binding to the plasma membrane, in-
ternalization and endosome-disruption activity are
three crucial steps intervening in adenovirus infection
w x29,30 . Short treatment of adenovirus with UV has
been reported to be without effect on adenovirus
infectivity, suggesting that viral genome plays no
w xobvious role in this process 31 . We wondered
whether UV-treated adenovirus would be efficient for
lipoadenofection. We used a complex of pSV2-CAT
with lipofectAMINE in a 1r10 positive charge ratio
for lipofection of 3T3-F442A adipocytes in the ab-
sence or in the presence of either native or UV-treated
non-replicative type 5 adenovirus. As expected from
w xour previous findings 12 , the presence of adenovirus
is highly beneficial to lipofection, with a 50-fold
 .increase in CAT activity Fig. 1 . Lipoadenofection
efficiency was entirely conserved at 1 min of treat-
ment of adenovirus with a 260 nm UV light, reduced
 .by about 30% at 2 min and by 60% at 5 min Fig. 1 .
In contrast, a 1 min UV-treatment was sufficient to
prevent adenovirus infection by 90%, as determined
by Ad-RSV-nlsLacZ-mediated b-galactosidase ex-
 .pression Fig. 1 . Longer exposure to UV light totally
inhibited infection. The deleterious effect of 1 min
UV-treatment on adenovirus infectivity, together with
the maintenance of maximal transfer of the plasmid
indicated that integrity of the viral genome was not
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required for lipoadenofection. This result was in ac-
cordance with previous observations showing that
UV-treated adenovirus still supported delivery of ei-
w xther naked DNA 32 or transferrin–polylysine–DNA
w xconjugates 31 into cultured cells, while its ability to
replicate on 293 cells was obviated.
Next we exposed the adenovirus preparation to
458C for 10 min. Such a treatment was reported to
alter capsid proteins in such a way that a large
w xdecrease in adenovirus infectivity 29 and endoso-
w xmolytic activity 23 was observed. This heat-in-
activated adenovirus was used in lipoadenofection
experiments. As shown in Fig. 1, CAT activity re-
mained identical to that obtained with lipofec-
tAMINE alone, showing that viral capsid was essen-
tial for the enhancement of liposome-mediated gene
transfer by adenovirus. A similar dependence of unal-
tered adenoviral capsid proteins for gene transfer
accomplished by the receptor-mediated transferrin–
w xpolylysine system has been described already 33 .
3.2. DNA, liposomes and adeno˝irus form a complex
that enter cells ˝ia the adeno˝irus-mediated endo-
cytic process
We wondered whether adenovirus would associate
with the lipofectAMINE–DNA complex to form a
higher ordered complex that would penetrate cells via
endocytosis. Electron microscopy observations
showed that negatively stained lipofectAMINE–DNA
complexes appeared as dense aggregates resembling
w xthose observed with other cationic lipids 3,7 , al-
though much larger as a consequence of using an-
 .ionic aggregating phosphotungstate instead of
 .uranyle acetate as contrasting agent Fig. 2A . Adeno-
virus bound avidly to these condensed structures Fig.
.2B . 3T3-F442A cells were treated for 30 min with a
suspension containing the resulting ternary complex,
the fate of which was examined by electron mi-
croscopy. Condensed structures were found in the
vicinity of the cell membrane and in endocytic vesi-
cles holding several lipid-coated adenovirus particles
 .Fig. 2C–D . Adenovirus-free lipofectAMINE–DNA
complexes were also found in endocytic vesicles not
. w xshown as expected from previous works 7,6 . Peri-
odicity of the lamellar structures was of approxi-
mately 5.5–7 nm a size close to that reported using
w xdifferent cationic lipids 7,34 , giving rise to multi-
 .lamellar structures of 70–150 nm Fig. 2E . In the
course of lipoadenofection, each adenovirus particle
with a core of 65 nm, was encompassed by 3 lipidic
 .bilayers of identical sizes 3.5–5 nm separated each
by 3 nm and presenting an hexaedric conformation
 .Fig. 2F . The resulting highly ordered structure had
a diameter of 110 nm. In such a structure, the plas-
mid DNA is likely to be condensed between the lipid
w xbilayers 35 .
We next wondered whether the route taken by
adenovirus to penetrate cells was of importance for
the lipoadenofection process. Adenovirus enters cells
by endocytosis after binding to a still unidentified
 .cellular receptor see Note on p. 15 via penton fiber,
w xa protein of the capsid, 37.6 nm in length 36–38 .
Internalization requires intervention of a b andv 3
a b integrins thought to interact with the RGDv 5
sequence of penton base, another protein of the cap-
w xsid 39–42 . Because of the size of the lipofec-
tAMINE–DNA–adenoviral core complex see above
.  .and Fig. 2F we postulated that part about 12 nm of
Fig. 1. Role of adenovirus capsid and viral genome for lipoade-
nofection efficiency. 3T3-F442A adipocytes were transfected for
 .  .7 h by lipofection Lfa or lipoadenofection Lfaqadenovirus .
 y1.Either native adenovirus 200 pfu cell , or adenovirus treated
 .with UV for 1, 2 or 5 min or with heat 458C for 10 min was
used or not. After transfection, cells were incubated with serum-
containing medium for 17 h before harvesting and determination
of CAT activity. Values of CAT activity are expressed in percent
of that obtained by lipoadenofection carried out with native
adenovirus. Each value represents the mean"SEM of data ob-
tained from three independent experiments with duplicate dishes.
100% represents 231"61 mU CAT mg proteiny1.
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the penton fibre protruded out of the complex and
remained able to interact with the adenovirus receptor
 .Fig. 3 .
For blocking penton fiber, we used a polyclonal
adenovirus antiserum previously obtained in immu-
w xnization experiments 28 . We incubated adenovirus
with either this antiserum or the pre-immune counter-
part before mixing with the lipofectAMINE–DNA
complex and proceeding to lipoadenofection of 3T3-
F442A adipocytes. Results are presented in Fig. 4. As
expected, adenovirus augmented lipofectAMINE-
mediated gene transfer as quantified by CAT activity
measurement. Adenovirus anti-serum prevented this
increase by 80%, whereas pre-immune serum had no
effect. Hence, we could speculate that lipofec-
tAMINE–DNA–adenovirus ternary complex forma-
tion did not impair interaction of penton fiber to the
adenovirus receptor. Therefore, in our transfection
procedure like in those employing either naked DNA
w x w x32 or transferrin–polylysine–DNA conjugates 18 ,
adenovirus appeared to use its own receptor for in-
creasing gene transfer efficiency.
For neutralizing a b integrin, we incubated cellsv 3
with a specific a b monoclonal antibody beforev 3
lipoadenofection. As shown in Fig. 4, this treatment
inhibited by about 40% the adenovirus-mediated in-
crease in CAT activity. Such a partial neutralization
was consistent with the potential involvement of a
second receptor, the a b integrin, in adenovirusv 5
w xinternalisation 41,43 . The mechanism by which the
Fig. 2. Electron photomicrographs of gene transfer reagents and of 3T3-F442A adipocytes transfected by lipoadenofection. Lipid–DNA
complex was prepared at a charge ratio of 10q then adenovirus was added or not. These reagents were observed under electron
microscope after negative stain or incubated with adipocytes for 30 min before electron microscopy. Negatively stained lipofectAMINE–
 .  .DNA complex are presented without panel A or with adenovirus panel B . Panels C and D show cells transfected by lipoadenofection,
 .at different magnifications. Panels E and F show endosomes containing lipid–DNA complexes without panel E or with adenovirus
 .panel F . Panels A, B, D, E, F: bar represents 100 nm. Panel C: bar represents 1 mM.
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Fig. 3. Schematic representation of the lipofectAMINE–
adenovirus complex. Figure drawn from electron micropho-
tographs identical to that of Fig. 2F represents adenovirus encap-
sulated in 3 lipid bilayers.
RGD sequence of penton base interact with integrins
for allowing lipoadenofection to proceed is presently
unknown.
Hence, both adenovirus receptor and a b inte-v 3
grin appeared to play a role in the adenovirus-in-
duced increase in lipofection. These results associated
to the electron microscopic observations strongly
suggested that lipofectAMINE–DNA–adenovirus
ternary complexes penetrated cells via receptor-medi-
ated endocytosis, leading to lipoadenofection.
3.3. Neutralization of endosomal pH does not affect
lipoadenofection
We wondered whether both components of the
vector system, i.e., adenovirus and lipofectAMINE
were equally important for plasmid delivery from the
endosomal compartment to the cytoplasm. One alter-
native to dissociate the respective roles of liposome
and adenovirus was to neutralize the pH of intra-
cellular compartment. We treated cells with either
 .weak bases chloroquine, ammonium chloride or a
 .ionophore monensin , all agents known to be effi-
cient for neutralizing pH of the intracellular compart-
w xments 44,45 . We controlled this neutralizing action
by incubating cells for 30 min with these agents then
30 min with acridine orange, a fluorescent molecule
able to specifically stain acidic intracellular compart-
w xments 46 . Indeed, fluorescent spots were strongly
attenuated in cells incubated with the neutralizing
agents when compared to those present in acridine
 .orange-only treated cells Fig. 5 .
Cells were transfected by lipoadenofection in the
presence or not of either chloroquine, ammonium
chloride or monensin and CAT gene expression was
measured. A 3.6-fold increase in CAT activity was
obtained when chloroquine was used, whereas ammo-
 .nium chloride or monensin had no effect Table 1 . In
contrast, in lipofectAMINE only-transfected cells, re-
ductions of 40%, 75% or 95% in gene transfer were
obtained by treatments with respectively chloroquine,
 .ammonium chloride or monensin Table 1 . One
interpretation for these results could be that these
reductions would be the consequence of a decrease in
the endosomolytic potential of dioleoylphosphatidyl
Fig. 4. Effect of anti-adenovirus and anti a b integrin antibod-v 3
ies on lipoadenofection efficiency. 3T3-F442A Adipocytes were
transfected as described in the legend to Fig. 1 using either native
 y1.or neutralized adenovirus 200 pfu cell . Adenovirus was
treated with either a polyclonal adenovirus antiserum from rabbit
or the pre-immune counterpart for 30 min at 378C. For a bv 3
integrin neutralization, adipocytes were pretreated with hamster
 .anti-mouse monoclonal anti-b IgG Anti-avb3 MAB for 30 min3
before proceeding to lipoadenofection. Cells were next incubated
with serum-containing medium for 17 h before harvesting and
determination of CAT activity. Values of CAT activity are
expressed in percent of that achieved by lipoadenofection per-
formed with native adenovirus. Each value represents the mean"
SEM of data obtained from three independent experiments with
duplicate dishes. 100% represents 164"57 mU CAT mg pro-
teiny1. Lfa, lipofectAMINE; CTL, control.
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Table 1
Effect of weak bases and ionophores on transgene expression
 .Transgene expression % of control
Control Chloroquine Ammonium Monensin .100 mM chloride  .5 mM
 .10 mM
Lipoadenofection 100 357"43 108"9 99 "32
Lipofection 100 64"14 24"10 4.4"1.2
Infection 100 145"17 99"2 114"18
3T3-F442A adipocytes were pretreated with either 100 mM
chloroquine, 10 mM ammonium chloride or 5 mM monensin for
30 min, then lipoadenofection LipofectAMINE 10q associated
y1. with Ad-RSV-nlsLacZ, 200 pfu cell , lipofection Lipo-
.  y1.fectAMINE 10q or infection Ad-RSV-nlsLacZ, 200 pfu cell
were carried out for 7 h. 17 h later cells were harvested and CAT
 .  .lipofection, lipoadenofection or b-galactosidase infection ac-
tivities were determined. Values of transgene expression are
expressed in percent of that of control cells. Each value repre-
sents the mean"SEM of data obtained from three independent
experiments with duplicate dishes. 100% CAT activity represents
227"70 mU mg proteiny1 and 11"3 mU mg proteiny1 for
lipoadenofection and lipofection, respectively. 100% b-galacto-
sidase activity represents 374"36 mU mgy1 hy1 for adenovirus
infection.
 .ethanolamine DOPE present in lipofectAMINE,
w xwhen pH is raised to neutral as reported 47 . Interest-
ingly, b-galactosidase activity from adenovirus-in-
fected cells augmented 1.45-fold in the presence of
chloroquine and was unaffected by ammonium chlo-
 .ride or monensin Table 1 . This result was at first
glance unexpected considering the dogma that adeno-
virus-mediated disruption of membranes of endocytic
w xvesicles required the acidic pH of endosomes 48,49 .
However, validity of this dogma is still a matter of
debate. Indeed, recent data indicate that weak base
w xamines do not alter adenovirus uncoating 50 and our
results are in agreement with this observation.
The beneficial effect of chloroquine on lipoadeno-
fection efficiency cannot be attributed to the preven-
tion of plasmid DNA degradation by lysosomal nu-
cleases since ammonium chloride and monensin do
 .not augment CAT activity Table 1 . Rather, chloro-
quine may act by binding DNA in endosomes thereby
dissociating lipofectAMINE–DNA complex in a
manner similar to that postulated for glycosylated
w xpolylysine–DNA complex 51 . Taken together, our
results show that endosomotropic agent-linked modu-
lations of gene expression follow a similar pattern
after adenoviral infection or lipoadenofection and
show opposite traits after lipofection. Hence, delivery
of DNA to the cytoplasm during lipoadenofection is
likely to be the result of adenovirus endosomolytic
activity.
 .Fig. 5. Acridine orange stained adipocytes. 3T3-F442A adipocytes were incubated in serum-free medium control: panel A containing
 .  .  .either 100 mM chloroquine panel B , 10 mM ammonium chloride panel C or 5 mM monensin panel D for 30 min then 1 mM acridine
orange was added for 30 min. Cells were immediately observed under fluorescent microscope with a 546 nm filter. Bar indicates 100 mm.
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In conclusion, the association of adenovirus and
lipofectAMINE permits the efficient transfer and ex-
pression of plasmid DNA in differentiated cells via a
process which involves the adenovirus receptor and
a b integrin for endocytosis of the ternary complexv 3
and in which viral genome is not essential whereas
adenoviral endosomolytic activity seems to be re-
quired. Determining the structural conformation of
the active complex and delineating the mechanism by
which adenovirus enhances cationic liposome-media-
ted gene transfer are prerequisites towards the design
of adequate synthetic vectors for gene therapy proce-
dures.
Note added in proof
While this paper was under review, Hong et al.
w x52 reported that the conserved region of MHC class
I a2 domain represents a high affinity receptor for
adenovirus type 5 fiber knob.
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